These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 38311516)

  • 21. HSP90 expression and early recurrence in gastroenteropancreatic neuroendocrine tumors: Potential for a novel therapeutic target.
    Gamboa AC; Ethun CG; Postlewait LM; Lopez-Aguiar AG; Zhelnin K; Krasinskas A; El-Rayes BF; Russell MC; Kooby DA; Staley CA; Cardona K; Maithel SK
    Surg Oncol; 2020 Dec; 35():460-465. PubMed ID: 33080545
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Survival and Symptomatic Relief After Cytoreductive Hepatectomy for Neuroendocrine Tumor Liver Metastases: Long-Term Follow-up Evaluation of More Than 500 Patients.
    Gudmundsdottir H; Habermann EB; Vierkant RA; Starlinger P; Thiels CA; Warner SG; Smoot RL; Truty MJ; Kendrick ML; Halfdanarson TR; Nagorney DM; Cleary SP
    Ann Surg Oncol; 2023 Aug; 30(8):4840-4851. PubMed ID: 37208566
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Resection of the primary pancreatic neuroendocrine tumor in patients with unresectable liver metastases: possible indications for a multimodal approach.
    Bertani E; Fazio N; Botteri E; Chiappa A; Falconi M; Grana C; Bodei L; Papis D; Spada F; Bazolli B; Andreoni B
    Surgery; 2014 Apr; 155(4):607-14. PubMed ID: 24582492
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Laparoscopic radiofrequency ablation of neuroendocrine liver metastases: a 10-year experience evaluating predictors of survival.
    Mazzaglia PJ; Berber E; Milas M; Siperstein AE
    Surgery; 2007 Jul; 142(1):10-9. PubMed ID: 17629995
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term survival after surgical management of neuroendocrine hepatic metastases.
    Glazer ES; Tseng JF; Al-Refaie W; Solorzano CC; Liu P; Willborn KA; Abdalla EK; Vauthey JN; Curley SA
    HPB (Oxford); 2010 Aug; 12(6):427-33. PubMed ID: 20662794
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatic Resection for Non-functional Neuroendocrine Liver Metastasis: Does the Presence of Unresected Primary Tumor or Extrahepatic Metastatic Disease Matter?
    Xiang JX; Zhang XF; Beal EW; Weiss M; Aldrighetti L; Poultsides GA; Bauer TW; Fields RC; Maithel SK; Marques HP; Pawlik TM
    Ann Surg Oncol; 2018 Dec; 25(13):3928-3935. PubMed ID: 30218247
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gastroenteropancreatic Neuroendocrine Tumors with Liver Metastases in Korea: A Clinicopathological Analysis of 72 Cases in a Single Institute.
    Shin Y; Ha SY; Hyeon J; Lee B; Lee J; Jang KT; Kim KM; Park YS; Park CK
    Cancer Res Treat; 2015 Oct; 47(4):738-46. PubMed ID: 25687852
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metastatic neuroendocrine tumors of the gastrointestinal tract and pancreas: A surgeon's plea to centering attention on the liver.
    Keutgen XM; Schadde E; Pommier RF; Halfdanarson TR; Howe JR; Kebebew E
    Semin Oncol; 2018 Aug; 45(4):232-235. PubMed ID: 30318110
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuroendocrine Tumors of the Pancreatobiliary and Gastrointestinal Tracts.
    Bonds M; Rocha FG
    Surg Clin North Am; 2020 Jun; 100(3):635-648. PubMed ID: 32402306
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatic ablation for neuroendocrine tumor metastases.
    Maithel SK; Fong Y
    J Surg Oncol; 2009 Dec; 100(8):635-8. PubMed ID: 20017158
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Surgical management of neuroendocrine tumors.
    Tamburrino D; Spoletini G; Partelli S; Muffatti F; Adamenko O; Crippa S; Falconi M
    Best Pract Res Clin Endocrinol Metab; 2016 Jan; 30(1):93-102. PubMed ID: 26971846
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Liver resection for non-colorectal, non-neuroendocrine hepatic metastases].
    Lang H; Nussbaum KT; Weimann A; Raab R
    Chirurg; 1999 Apr; 70(4):439-46. PubMed ID: 10354843
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Resection of the primary tumor improves survival in patients with gastro-entero-pancreatic neuroendocrine neoplasms with liver metastases: A SEER-based analysis.
    Zheng M; Li Y; Li T; Zhang L; Zhou L
    Cancer Med; 2019 Sep; 8(11):5128-5136. PubMed ID: 31328428
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term outcomes following 90Y Radioembolization of neuroendocrine liver metastases: evaluation of the radiation-emitting SIR-spheres in non-resectable liver tumor (RESiN) registry.
    Wong TY; Zhang KS; Gandhi RT; Collins ZS; O'Hara R; Wang EA; Vaheesan K; Matsuoka L; Sze DY; Kennedy AS; Brown DB
    BMC Cancer; 2022 Mar; 22(1):224. PubMed ID: 35232410
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictive factors associated with long-term survival in patients with neuroendocrine tumors of the pancreas.
    Chu QD; Hill HC; Douglass HO; Driscoll D; Smith JL; Nava HR; Gibbs JF
    Ann Surg Oncol; 2002 Nov; 9(9):855-62. PubMed ID: 12417506
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Liver transplantation for unresectable neuroendocrine tumor liver metastases.
    Rossi RE; Burroughs AK; Caplin ME
    Ann Surg Oncol; 2014 Jul; 21(7):2398-405. PubMed ID: 24562931
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Isolated liver metastases from neuroendocrine tumors: does resection prolong survival?
    Chen H; Hardacre JM; Uzar A; Cameron JL; Choti MA
    J Am Coll Surg; 1998 Jul; 187(1):88-92; discussion 92-3. PubMed ID: 9660030
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Liver trasplantation for the treatment of non-resectable metastases of neuroendocrine tumors: first report in Argentina].
    Quiñonez E; Capitanich P; Anders M; Fernández JL; Serafini V; Viola L; Mastai R; McCormack L
    Acta Gastroenterol Latinoam; 2011 Sep; 41(3):242-6. PubMed ID: 22233004
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Histologic grade is correlated with outcome after resection of hepatic neuroendocrine neoplasms.
    Cho CS; Labow DM; Tang L; Klimstra DS; Loeffler AG; Leverson GE; Fong Y; Jarnagin WR; D'Angelica MI; Weber SM; Blumgart LH; Dematteo RP
    Cancer; 2008 Jul; 113(1):126-34. PubMed ID: 18457323
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pancreatic neuroendocrine tumor: A multivariate analysis of factors influencing survival.
    Birnbaum DJ; Turrini O; Ewald J; Barbier L; Autret A; Hardwigsen J; Brunet C; Moutardier V; Le Treut YP; Delpero JR
    Eur J Surg Oncol; 2014 Nov; 40(11):1564-71. PubMed ID: 25086992
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.